Cannabis Terpene Myrcene Reduced Arthritis Pain and Inflammation in Rats

The cannabis terpene myrcene reduced chronic joint pain and inflammation in arthritic rats through cannabinoid receptors, but adding CBD did not enhance the effect.

McDougall, Jason J et al.·International journal of molecular sciences·2022·Moderate EvidenceAnimal StudyAnimal Study
RTHC-04056Animal StudyModerate Evidence2022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Local application of myrcene (1 and 5 mg/kg) reduced joint pain and inflammation in rats with chronic arthritis via a cannabinoid receptor mechanism. However, combining myrcene with CBD (200 ug) was not significantly different from myrcene alone. Repeated myrcene treatment had no effect on joint damage or inflammatory cytokine levels.

Key Numbers

Myrcene: 1 and 5 mg/kg subcutaneous; CBD: 200 ug; assessed at days 7 and 21; pain relief via cannabinoid receptor mechanism confirmed

How They Did This

Chronic arthritis was induced in male Wistar rats by intra-articular injection. Joint pain (von Frey hair algesiometry), inflammation (intravital microscopy, laser speckle), and histopathology were assessed on days 7 and 21 after induction.

Why This Research Matters

The "entourage effect" theory suggests cannabis terpenes enhance cannabinoid effects. This study found myrcene works through cannabinoid receptors on its own but does not synergize with CBD, challenging assumptions about entourage synergy.

The Bigger Picture

Terpenes are increasingly recognized as pharmacologically active, not just aromatic compounds. Myrcene working through cannabinoid receptors suggests terpenes can independently contribute to cannabis therapeutic effects.

What This Study Doesn't Tell Us

Animal study in male rats only. Subcutaneous injection does not replicate typical human use. Only one terpene-cannabinoid combination tested.

Questions This Raises

  • ?Would myrcene synergize with THC rather than CBD for pain?
  • ?Could topical myrcene formulations be developed for arthritis treatment in humans?

Trust & Context

Key Stat:
Myrcene worked via cannabinoid receptors but no synergy with CBD
Evidence Grade:
Well-designed animal study with multiple outcome measures, but limited to male rats and one terpene-cannabinoid combination.
Study Age:
Published in 2022
Original Title:
Anti-Inflammatory and Analgesic Properties of the Cannabis Terpene Myrcene in Rat Adjuvant Monoarthritis.
Published In:
International journal of molecular sciences, 23(14) (2022)
Database ID:
RTHC-04056

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Does myrcene help with pain?

In this rat study, locally applied myrcene reduced chronic arthritis pain and inflammation through cannabinoid receptor activation. The effect was confirmed by blocking with a cannabinoid antagonist.

Did myrcene and CBD work better together?

No. Combining myrcene with CBD was not significantly better than myrcene alone, challenging the common assumption that terpenes always enhance cannabinoid effects.

Read More on RethinkTHC

Cite This Study

RTHC-04056·https://rethinkthc.com/research/RTHC-04056

APA

McDougall, Jason J; McKenna, Meagan K. (2022). Anti-Inflammatory and Analgesic Properties of the Cannabis Terpene Myrcene in Rat Adjuvant Monoarthritis.. International journal of molecular sciences, 23(14). https://doi.org/10.3390/ijms23147891

MLA

McDougall, Jason J, et al. "Anti-Inflammatory and Analgesic Properties of the Cannabis Terpene Myrcene in Rat Adjuvant Monoarthritis.." International journal of molecular sciences, 2022. https://doi.org/10.3390/ijms23147891

RethinkTHC

RethinkTHC Research Database. "Anti-Inflammatory and Analgesic Properties of the Cannabis T..." RTHC-04056. Retrieved from https://rethinkthc.com/research/mcdougall-2022-antiinflammatory-and-analgesic-properties

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.